Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report.

Ana Misir KrpanZoran RakusicDavorin Herceg

Published in: Medicine (2021)

Our report describes durable intracranial tumor response suggesting the efficacy of PD-1 inhibitor pembrolizumab for central nervous system primary leptomeningeal melanoma.

Keyphrases

cerebrospinal fluid
advanced non small cell lung cancer
brain metastases
small cell lung cancer
skin cancer
basal cell carcinoma